INSM
Insmed Incorporated · Healthcare · Biotechnology
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | -6 | 147.56M | $15.74B | +6 | −11 |
| Q1 2026 | 166 | +6 | 152.11M | $24.63B | +9 | −4 |
| Q4 2025 | 159 | -1 | 156.45M | $27.23B | +1 | −1 |
| Q3 2025 | 21 | +1 | 121.03M | $17.43B | +1 | −1 |
| Q2 2025 | 18 | +1 | 70.35M | $7.08B | +2 | −1 |
| Q1 2025 | 14 | -1 | 33.99M | $2.59B | — | −1 |
| Q4 2024 | 15 | 0 | 31.46M | $2.17B | +1 | −1 |
| Q3 2024 | 14 | -1 | 23.46M | $1.71B | — | −1 |
| Q2 2024 | 15 | — | 25.91M | $1.74B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 12.16M | — | $814.95M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 12.16M | — | $814.95M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passiv) | 3.64M | — | $243.98M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 3.64M | — | $243.98M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Norges Bank ✦ (passiv) | 1.76M | — | $117.75M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Adage Capital Partners ✦ | 1.32M | — | $88.78M | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Adage Capital Partners ✦ | 1.32M | — | $88.78M | 0.2% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 1.25M | — | $83.71M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Millennium Management ✦ | 1.20M | — | $80.30M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.20M | — | $80.30M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Viking Global Investors ✦ | 1.04M | — | $69.41M | 0.3% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 938.43K | — | $62.88M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 938.43K | — | $62.88M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 938.43K | — | $62.88M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Wellington Management ✦ | 938.43K | — | $62.88M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 938.43K | — | $62.88M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 938.43K | — | $62.88M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Point72 Asset Management ✦ | 858.30K | — | $57.51M | 0.2% | n/c | 1 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 858.30K | — | $57.51M | 0.2% | n/c | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 799.75K | — | $53.58M | 0.1% | n/c | 1 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 799.75K | — | $53.58M | 0.1% | n/c | 1 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 799.75K | — | $53.58M | 0.1% | n/c | 1 | SEC ↗ |
| 23 | Soros Fund Management ✦ | 470.70K | — | $31.54M | 1.0% | n/c | 1 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 288.55K | — | $19.33M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 288.55K | — | $19.33M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Two Sigma Investments ✦ | 107.74K | — | $7.22M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 60.53K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 60.53K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Duquesne Family Office ✦ | 20.00K | — | $1.34M | 0.0% | n/c | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 664 Inhaber, 192.22M Anteile, $30.07B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Director · 5.00K Ant. · $637,650
Officer · 239.85K Ant. · $31.96M
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik